Search for: "Novartis Pharmaceuticals v. Watson Laboratories, Inc."
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
18 Dec 2009, 9:59 am
Watson Laboratories, Inc.- Florida, Watson Pharma Inc. and Watson Pharmaceuticals Inc. [read post]
16 Oct 2006, 7:58 pm
Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
28 Jul 2010, 12:06 am
Watson Laboratories, Inc. [read post]
15 Jun 2011, 4:56 am
Watson Pharmaceuticals, Inc. et al. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
6 Apr 2011, 12:18 am
Chiron Healthcare & Novartis (EPLAW) India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US:… [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) Trileptal (Oxacarbazepine) - Israel Patent Office prevents Novartis from submitting empirical evidence in patent opposition case (IP Factor) Vesicare (Solifenacin) – US: Astellas files patent infringement lawsuit against Teva over generic Vesicare (GenericsWeb) Zyprexa (Olanzapine) – Canada: Teva Novopharm invalidates Eli Lilly’s Canadian patent for Olanzapine (IP… [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
6 Jul 2011, 2:21 am
Biopet Vet Lab, Inc., et. al. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
